𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myeloma

✍ Scribed by Giuseppe Mele; Salvatore Pinna; Emilia Alloro; Maurizio Claudio Brocca; Maria Rosaria Coppi; Giovanni Quarta

Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
64 KB
Volume
31
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neurotoxicity of bortezomib therapy in m
Neurotoxicity of bortezomib therapy in multiple myeloma: A single-center experience and review of the literature
✍ Ashraf Badros; Olga Goloubeva; Jay S. Dalal; Ilyas Can; Jennifer Thompson; Aaron πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Bortezomib is active in heavily pretreated multiple myeloma patients; the dose‐limiting toxicity is peripheral neuropathy (PN). ## METHODS. The authors retrospectively reviewed the incidence, severity, and risk factors for PN in 78 patients who received bortezomib. The